Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-11.09%Return on Equity
VS
Market
Sector
Industry
History
$ 0.54Close
$ 0.39 - $ 1.72 52-Week Range
Ticker Information
Ticker
IPSCCompany Name
CENTURY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCENTURY THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IPSC - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 209.9M | $ -23.28M | -11.09% |
| 3/31/2025 | $ 240.44M | $ -21.95M | -9.13% |
| 12/31/2024 | $ 161.36M | $ -126.57M | -78.44% |
| 9/30/2024 | $ 195.69M | $ -129.89M | -66.38% |
| 6/30/2024 | $ 222.1M | $ -131.39M | -59.16% |
| 3/31/2024 | $ 177.88M | $ -133.47M | -75.03% |
| 12/31/2023 | $ 184.75M | $ -136.67M | -73.98% |
| 9/30/2023 | $ 219.23M | $ -128.96M | -58.82% |
| 6/30/2023 | $ 247.57M | $ -126.99M | -51.29% |
| 3/31/2023 | $ 277.18M | $ -124.68M | -44.98% |
Key Performance Insights, Last 5 Years
- CENTURY THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, CENTURY THERAPEUTICS INC's average ROE has been -46.56%.
- The median ROE for CENTURY THERAPEUTICS INC during this period was -44.98%
- CENTURY THERAPEUTICS INC reached its highest ROE over the past 5 years at -9.13%.
- The lowest ROE recorded by CENTURY THERAPEUTICS INC in the same timeframe -78.44%
CENTURY THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CENTURY THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -53.58M ] / Equity [ $ -106.41M ]
(=) ROE [ 0% ] IPSC - Return on Equity, Last 5 years
-78.44%
Minimum
Dec 31, 2024
-9.13%
Maximum
Mar 31, 2025
-46.56%
Average
-44.98%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |